Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomised, double-blind, double dummy, 3 way crossover study evaluating the effects of a combination of Seretide 50/500mcg twice daily plus tiotropium bromide 18mcg once daily compared with the individual agents (tiotropium bromide 18mcg alone and Seretide50/500mcg alone) in the treatment of subjects with COPD
fluticasone propionate/salmeterol
SCO104962
NCT00325169
Pulmonary Disease, Chronic Obstructive
Phase 2
 
March 2014

Powered by ideaPoint, Inc.